ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Merdol Ibrahim; Suzanne Parry; Dawn Wilkinson; Neil Bilbe; David Allen; Steven Forrest; Perry Maxwell; Anthony O'Grady; Jane Starczynski; Philippe Tanier; John Gosney; Keith Kerr; Keith Miller; Erik Thunnissen

doi:10.1016/j.jtho.2016.07.012

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Merdol Ibrahim, Suzanne Parry, Dawn Wilkinson, Neil Bilbe, David Allen, Steven Forrest, Perry Maxwell, Anthony O'Grady, Jane Starczynski, Philippe Tanier, John Gosney, Keith Kerr, Keith Miller, Erik Thunnissen

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2241-2247
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	12
DOIs	https://doi.org/10.1016/j.jtho.2016.07.012
Publication status	Published - Dec 2016

Access to Document

10.1016/j.jtho.2016.07.012

Cite this

Ibrahim, M., Parry, S., Wilkinson, D., Bilbe, N., Allen, D., Forrest, S., Maxwell, P., O'Grady, A., Starczynski, J., Tanier, P., Gosney, J., Kerr, K., Miller, K., & Thunnissen, E. (2016). ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. Journal of Thoracic Oncology, 11(12), 2241-2247. https://doi.org/10.1016/j.jtho.2016.07.012

@article{6a34d8f086dc408d93759bb555d9a017,

title = "ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen",

keywords = "ALK IHC, NSCLC, Immunohistochemistry, External quality assessment",

author = "Merdol Ibrahim and Suzanne Parry and Dawn Wilkinson and Neil Bilbe and David Allen and Steven Forrest and Perry Maxwell and Anthony O'Grady and Jane Starczynski and Philippe Tanier and John Gosney and Keith Kerr and Keith Miller and Erik Thunnissen",

year = "2016",

month = dec,

doi = "10.1016/j.jtho.2016.07.012",

language = "English",

volume = "11",

pages = "2241--2247",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "12",

}

Ibrahim, M, Parry, S, Wilkinson, D, Bilbe, N, Allen, D, Forrest, S, Maxwell, P, O'Grady, A, Starczynski, J, Tanier, P, Gosney, J, Kerr, K, Miller, K & Thunnissen, E 2016, 'ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen', Journal of Thoracic Oncology, vol. 11, no. 12, pp. 2241-2247. https://doi.org/10.1016/j.jtho.2016.07.012

TY - JOUR

T1 - ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

AU - Ibrahim, Merdol

AU - Parry, Suzanne

AU - Wilkinson, Dawn

AU - Bilbe, Neil

AU - Allen, David

AU - Forrest, Steven

AU - Maxwell, Perry

AU - O'Grady, Anthony

AU - Starczynski, Jane

AU - Tanier, Philippe

AU - Gosney, John

AU - Kerr, Keith

AU - Miller, Keith

AU - Thunnissen, Erik

PY - 2016/12

Y1 - 2016/12

KW - ALK IHC

KW - NSCLC

KW - Immunohistochemistry

KW - External quality assessment

U2 - 10.1016/j.jtho.2016.07.012

DO - 10.1016/j.jtho.2016.07.012

M3 - Article

C2 - 27468935

VL - 11

SP - 2241

EP - 2247

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 12

ER -